Join us for a webinar led by Dr. Angie Serrano.
April 22, 2025 at 8:00 pm EST (US and Canada)
Format:
Zoom talk and a Q&A session
Topic:
In 2022 the KAT6 Foundation and collaborators established the first patient-derived induced Pluripotent Stem Cells (iPSC) bank for KAT6A and KAT6B variants. The foundation’s Science Advisor, Dr. Angie Serrano, stores and maintains biospecimens, such as, skin and blood samples of KAT6A and KAT6B patients at Boston University. Join us to learn about recent progress in the KAT6 Pluripotent Stem Cell Bank and on how studying blood samples with advance spectral flow cytometry methods helps understand the biology of KAT6 Disorders.
Part 1 | KAT6 Biobank status update
About the Presenter:
Dr. Serrano is an Assistant Professor of Medicine at the Center for Regenerative Medicine (CReM), Boston University. Dr. Serrano’s research program aims to develop pioneering work towards understanding shared cellular and molecular mechanisms of neurodevelopment and vasculogenesis in the context of rare diseases with an epigenetic basis. To reach this goal, Dr. Serrano combines her expertise in rare disease modeling in zebrafish together with cardiovascular and neurobiology techniques and human iPSC-derived brain organoids and endothelial cells. Dr. Serrano’s approach to rare disease research is based on the proactive establishment of interdisciplinary collaborations with institutional and external field experts in vascular biology, neurobiology, pediatrics, regenerative and precision medicine together with patient advocacy groups.
Join Us on Zoom:
Learn more about the research opportunities that the KAT6 biobank could offer our rare community. Join the discussion and ask your questions to Dr. Serrano.
You can obtain the Zoom link in the KAT6 Support Group on Facebook, or email support@kat6a.org.
KAT6 families visit CReM at Boston University on March 31, 2023